# Pharmacokinetic Study in Healthy Males

> **NCT02312232** · PHASE1 · COMPLETED · sponsor: **Orion Corporation, Orion Pharma** · enrollment: 20 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** levodopa, carbidopa, ODM-104

## Key facts

- **NCT ID:** NCT02312232
- **Lead sponsor:** Orion Corporation, Orion Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2015-02
- **Final completion:** 2015-02
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2015-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02312232

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02312232, "Pharmacokinetic Study in Healthy Males". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02312232. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*